Market Place
Sourcing Support
Zyus Life Sciences Corporation Announces Closing of Unsecured Loan
27 Sep 2024 //
BUSINESSWIRE
ZYUS Life Sciences Receives Health Canada NOL For Proof-Of-Concept Trial
30 Jul 2024 //
BUSINESSWIRE
ZYUS Life Sciences Receives Cannabis Drug License from Health Canada
04 Jun 2024 //
BUSINESSWIRE
ZYUS Announces Completion of Its Annual Filings
07 May 2024 //
BUSINESSWIRE
ZYUS Life Sciences At Sidoti Investor Conference May 8-9
07 May 2024 //
BUSINESSWIRE
ZYUS Announces Anticipated Delay in Its Annual Filings
29 Apr 2024 //
BUSINESSWIRE
ZYUS Receives US Patent for Pain Management
23 Apr 2024 //
BUSINESSWIRE
ZYUS Strengthens Leadership Team with Appointment of VP of Clinical Research
09 Jan 2024 //
BUSINESSWIRE
ZYUS Life Sciences Corporation Announces Issuance of Shares for Debt Settlement
22 Dec 2023 //
BUSINESSWIRE
ZYUS Life Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin
05 Dec 2023 //
BUSINESSWIRE
ZYUS Life Sciences Corporation Reports Q3 2023 Results
29 Nov 2023 //
BUSINESSWIRE
ZYUS Life Announces Positive Phase I Trial Results for Trichomylin® Softgels
21 Nov 2023 //
BUSINESSWIRE
ZYUS Life Announces New Director of Investor Relations and Capital Markets
24 Oct 2023 //
BUSINESSWIRE
ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance
31 Aug 2023 //
BUSINESSWIRE
ZYUS Life Sciences Strengthen BOD with the Appointment of Wayne Brownlee
29 Jun 2023 //
BUSINESSWIRE
Rite Aid to Release First Quarter Results on June 29
12 Jun 2023 //
BUSINESSWIRE
ZYUS Life Sciences Corporation Announces Completion of RTO
12 Jun 2023 //
BUSINESSWIRE
ZYUS Announces Concurrent Private Placement of Subscription Receipts
28 Mar 2023 //
BUSINESSWIRE
ZYUS Announces Database Lock for its Phase 1 First-in-Human Clinical Trial
15 Nov 2022 //
BUSINESSWIRE
ZYUS Life Sciences Launches New Medical Cannabinoid Formulation in Canada
17 Nov 2021 //
BUSINESSWIRE
Zydus’ new tech enables initiative to safeguard patients counterfeit drugs
28 May 2021 //
DDNEWS
ZYUS Life Sciences Partners with Portugal’s Aureuspharma to Further Increase
27 May 2021 //
BUSINESSWIRE
ZYUS Life Sciences Partners with Portugal’s Aureuspharma to Further
27 May 2021 //
BUSINESSWIRE
ZYUS Launches HOPE (Human Osteoarthritis Pain Evaluation)
19 Apr 2021 //
BUSINESSWIRE
ZYUS Life science Appointmented Audrey Haukioja
18 Mar 2021 //
BUSINESSWIRE
ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine
15 Jul 2020 //
BUSINESSWIRE
ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine
07 May 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.